documents: FDA-2013-N-1525-0207
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2013-N-1525-0207 | FDA | FDA-2013-N-1525 | Cited Reference Martin-Moreno et al Prolonged Oral Cannabinoid Administration Prevents Neuroinflammation, Lowers b-amyloid Levels and Improves Cognitive Performance in Tg APP 2576 Mice RE: Request for Nomination from Gary Gray Pharmacist dba COMPLEX | Supporting & Related Material | Background Material | 2014-10-17T04:00:00Z | 2014 | 10 | 2015-03-23T19:51:17Z | 0 | 0 | 09000064818ad191 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref